X4 PHARMACEUTICALS INC's ticker is XFOR and the CUSIP is 98420X103. A total of 91 filers reported holding X4 PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 1.69 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,809,775 | -14.4% | 6,247,500 | +52.4% | 2.18% | -26.4% |
| Q2 2023 | $7,953,889 | +135.7% | 4,099,943 | +5.7% | 2.96% | +187.5% |
| Q1 2023 | $3,374,281 | -8.3% | 3,878,484 | +4.6% | 1.03% | -31.0% |
| Q4 2022 | $3,681,000 | -14.0% | 3,706,517 | +48.0% | 1.49% | +26.7% |
| Q3 2022 | $4,282,000 | +155.3% | 2,504,006 | +44.0% | 1.18% | +71.0% |
| Q2 2022 | $1,677,000 | -44.2% | 1,738,300 | +1.2% | 0.69% | -41.5% |
| Q1 2022 | $3,006,000 | -16.9% | 1,717,589 | +8.8% | 1.17% | -17.6% |
| Q4 2021 | $3,616,000 | – | 1,578,947 | – | 1.42% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Polaris Venture Management Co. V, L.L.C. | 311,492 | $2,109,000 | 3.48% |
| SV Health Investors, LLC | 311,490 | $2,109,000 | 1.07% |
| Bain Capital Life Sciences Investors, LLC | 1,648,485 | $11,160,000 | 1.04% |
| New Leaf Venture Partners, L.L.C. | 335,000 | $2,268,000 | 0.91% |
| Ikarian Capital, LLC | 724,680 | $4,907,000 | 0.36% |
| BVF INC/IL | 792,892 | $5,368,000 | 0.29% |
| Opaleye Management Inc. | 75,000 | $508,000 | 0.10% |
| Orbimed Advisors | 1,086,493 | $7,356,000 | 0.09% |
| RA Capital Management | 559,494 | $3,788,000 | 0.07% |
| Bleichroeder LP | 35,730 | $242,000 | 0.04% |